Authors: Resnik, David B; Tinkle, Sally S

Source: Nanomedicine, Volume 2, Number 3, June 2007 , pp. 345-350(6)

Publisher: Future Medicine

Abstract:

As the science and technology of nanomedicine speed ahead, ethics, policy and the law are struggling to keep up. It is important to proactively address the ethical, social and regulatory aspects of nanomedicine in order to minimize its adverse impacts on the environment and public health and also to avoid a public backlash. At present, the most significant concerns involve risk assessment, risk management of engineered nanomaterials and risk communication. Although in vivo animal experiments and ex vivo laboratory analyses can increase our understanding of the interaction of engineered nanomaterials in biological systems, they cannot eliminate all of the uncertainty surrounding the exposure of a human subject to nanomedicine products in clinical trials. Significant risks can still materialize after a product has cleared the Phase I hurdle and is in Phase II or III clinical trials. Furthermore, as the use of engineered nanomaterials in nanomedicine increases, questions of social justice, access to healthcare and the use of nanotechnology for physical enhancement become increasingly important.

Keywords: clinical trials; enhancement; ethics; nanomedicine; nanotechnology; risk; safety; social justice

Document Type: Research article

DOI: http://dx.doi.org/10.2217/17435889.2.3.345

Affiliations: 1: National Institute of Environmental Health Sciences and National Institutes of Health, Box 12233, Mail Drop NH06, Research Triangle Park, NC 27709, USA., Email: resnikd@niehs.nih.gov

Publication date: 2007-06-01

More about this publication?

• Nanomedicine is a uniquely medicine-focused journal in nanotechnology, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems, and nanorobotics.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• E-Access Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Technology ,  Medicine ,  Medicine (General)
• By this author: Resnik, David B ;  Tinkle, Sally S

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers